More Medicare Now Covers Genetic Tests for Targeting Depression Drugs
Wednesday, November 19, 2014
Medicare Now Covers Genetic Tests for Targeting Depression Drugs
An oral swab test that gives doctors an easy-to-read report to help guide decisions about prescribing depression medications is now available to 50 million Americans on Medicare.
More Medicare Now Covers Genetic Tests for Targeting Depression Drugs
More Medicare Now Covers Genetic Tests for Targeting Depression Drugs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment